Guidance

Cervical screening: laboratory testing for human papillomavirus

This document provides information on internal quality control and assurance procedures, and external quality assessment.

From:
NHS England
Published
25 January 2017
Last updated
26 September 2024 — See all updates

Documents

NHS Cervical Screening Programme: laboratory quality control and assurance for human papillomavirus testing

Ref: PHE publications gateway number: GW-557

HTML

Details

This document is for laboratories performing human papillomavirus (HPV) testing for the NHS Cervical Screening Programme (NHSCSP). It covers:

  • internal quality control (IQC)
  • internal quality assessment (IQA) procedures and monitoring
  • external quality assessment (EQA)

The guidance reflects the standards within ISO15189.

This publication was originally published by Public Health England, which closed on 30 September 2021.

Updates to this page

Published 25 January 2017
Last updated 26 September 2024 + show all updates

  1. Added clarification that publication was originally published by Public Health England.

  2. Updated to provide additional guidance on the use of IQC material and advice on training and competency requirements for staff using a new HPV platform.

  3. First published.

Sign up for emails or print this page

Related content